HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedEUCTR 2017-000069-57

A Multisite Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Addiction Treatment

This historical record does not confirm current site availability.

Historical research recordBulgaria + Netherlands
The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations
Bulgaria · Netherlands
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study clarity

Study information

Study start dateNot clearly listed
Recruitment status
Completed
Enrollment listed in the registry
210
Sponsor
BIOPROJET PHARMA
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Bulgaria, Netherlands
Age range
Not clearly listed
Official registry ID
EUCTR 2017-000069-57
Official title
Show the full official title

A Multisite Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Alcohol Use Disorder Treatment

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bulgaria · Netherlands

Checked Official study record (opens in a new tab)
Registry details
Historical country statuses
FAQ

Questions about this study

Who is behind this study?

The study sponsor is BIOPROJET PHARMA, a pharmaceutical company.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me